EcoDrugPlus

Phosphodiesterase 4b

Ensembl ID : ENSECRG00000009352
Gene Symbol: PDE4B
3 Cross references
304 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSECRG00000008174
Gene Symbol: PDE4D
3 Cross references
235 Possible Orthologues:

Phosphodiesterase 5a

Ensembl ID : ENSECRG00000008742
Gene Symbol: PDE5A
3 Cross references
210 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSECRG00000005574
Gene Symbol: PDE7A
3 Cross references
241 Possible Orthologues:

Phosphodiesterase 7b

Ensembl ID : ENSECRG00000012364
Gene Symbol: PDE7B
3 Cross references
174 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 1

Ensembl ID : ENSECRG00000009723
Gene Symbol: PIK3R1
3 Cross references
257 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 2

Ensembl ID : ENSECRG00000012627
Gene Symbol: PIK3R2
2 Cross references
252 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSECRG00000021169
Gene Symbol: PIK3R5
3 Cross references
256 Possible Orthologues:

Phospholipase A2 Group Vii

Ensembl ID : ENSECRG00000008501
Gene Symbol: PLA2G7
3 Cross references
206 Possible Orthologues:

Phospholipase A2-Like

Ensembl ID : ENSECRG00000010919
Gene Symbol: LOC114660069
3 Cross references
250 Possible Orthologues:

Phosphoribosylglycinamide Formyltransferase, Phosphoribosylglycinamide Synthetase, Phosphoribosylaminoimidazole Synthetase

Ensembl ID : ENSECRG00000015063
Gene Symbol: GART
3 Cross references
214 Possible Orthologues:

Plasminogen

Ensembl ID : ENSECRG00000001836
Gene Symbol: PLG
3 Cross references
273 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).